參考文獻 |
[1] Ahmad, I., Perkins, W. R., Lupan, D. M. et al., “Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1237, no. 2, pp. 109-114, 1995.
[2] Virtanen, J. A., Cheng, K. H., and Somerharju, P., “Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 9, pp. 4964-4969, 1998.
[3] Chan, D. I., Prenner, E. J., and Vogel, H. J., “Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1758, no. 9, pp. 1184-1202, 2006.
[4] Brogden, K. A., “Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?,” Nat Rev Micro, vol. 3, no. 3, pp. 238-250, 2005.
[5] Selsted, M. E., Novotny, M. J., Morris, W. L. et al., “Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils,” J. Biol. Chem., vol. 267, no. 7, pp. 4292-4295, 1992.
[6] Rozek, A., Friedrich, C. L., and Hancock, R. E. W., “Structure of the Bovine Antimicrobial Peptide Indolicidin Bound to Dodecylphosphocholine and Sodium Dodecyl Sulfate Micelles,” Biochemistry, vol. 39, no. 51, pp. 15765-15774, 2000.
[7] Revital Halevy, A. R., Sofiya Kolusheva, Robert E.W. Hancock, Raz Jelinek, “Membrane binding and permeation by indolicidin analogs studied by a biomimetic lipid/polydiacetylene vesicle assay,” Peptides, vol. 24, pp. 1753-1761, 2003.
[8] Ladokhin, A. S., Selsted, M. E., and White, S. H., “Bilayer Interactions of Indolicidin, a Small Antimicrobial Peptide Rich in Tryptophan, Proline, and Basic Amino Acids,” vol. 72, no. 2, pp. 794-805, 1997.
[9] Schluesener HJ, R. S., Melms A, Jung S., “Leukocytic antimicrobial peptides kill autoimmune T cells,” Journal of neuroimmunology, vol. 47, 1993.
[10] Giacometti, A., Cirioni, O., Greganti, G. et al., “In Vitro Activities of Membrane-Active Peptides against Gram-Positive and Gram-Negative Aerobic Bacteria,” Antimicrob. Agents Chemother., vol. 42, no. 12, pp. 3320-3324, 1998.
[11] Friedrich, C. L., Moyles, D., Beveridge, T. J. et al., “Antibacterial Action of Structurally Diverse Cationic Peptides on Gram-Positive Bacteria,” Antimicrob. Agents Chemother., vol. 44, no. 8, pp. 2086-2092, 2000.
[12] Falla, T. J., and Hancock, R. E., “Improved activity of a synthetic indolicidin analog,” Antimicrob. Agents Chemother., vol. 41, no. 4, pp. 771-775, 1997.
[13] Subbalakshmi, C., Krishnakumari, V., Sitaram, N. et al., “Interaction of indolicidin, a 13-residue peptide rich in tryptophan and proline and its analogues with model membranes,” J. Biosci., vol. 23, pp. 9-13, 1998.
[14] Lee, D. G., Kim, H. K., Kim, S. A. et al., “Fungicidal effect of indolicidin and its interaction with phospholipid membranes,” Biochemical and Biophysical Research Communications, vol. 305, no. 2, pp. 305-310, 2003.
[15] Stephen B. Aley, M. Z., Michel Hetsko, Michel E. Selsted, and Frances D. Gillin, “Killing of Giardia lamblia by Cryptdins and Cationic Neutrophil Peptides,” Infection and Immunity, vol. 62, no. 12, pp. 5397-5403, 1994.
[16] Robinson, W. E., McDougall, B., Tran, D. et al., “Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils,” J Leukoc Biol, vol. 63, no. 1, pp. 94-100, 1998.
[17] Vanesa, C. A. M., and Viviana, C., “Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus,” International journal of antimicrobial agents, vol. 23, no. 4, pp. 382-389, 2004.
[18] Falla, T. J., Karunaratne, D. N., and Hancock, R. E. W., “Mode of Action of the Antimicrobial Peptide Indolicidin,” J. Biol. Chem., vol. 271, no. 32, pp. 19298-19303, August 9, 1996, 1996.
[19] Yang Sung-Tae, Shin Song Yub, , K.-S. H. et al., “Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities,” International journal of antimicrobial agents, vol. 27, no. 4, pp. 325-330, 2006.
[20] Manhong Wu, E. M., Roland Benz, Robert E. W. Hancock, “Mechanism of Interaction of Different Classes of Cationic Antimicrobial Peptides with Planar Bilayers and with the Cytoplasmic Membrane of Escherichia coli,” Biochemistry, vol. 38, no. 22, pp. 7235-7242, 1999.
[21] Zhang, L., Rozek, A., and Hancock, R. E. W., “Interaction of Cationic Antimicrobial Peptides with Model Membranes,” J. Biol. Chem., vol. 276, no. 38, pp. 35714-35722, 2001.
[22] Yau, W.-M., Wimley, W. C., Gawrisch, K. et al., “The Preference of Tryptophan for Membrane Interfaces,” Biochemistry, vol. 37, no. 42, pp. 14713-14718, 1998.
[23] Norman, K. E., and Nymeyer, H., “Indole Localization in Lipid Membranes Revealed by Molecular Simulation,” Biophysical Journal, vol. 91, no. 6, pp. 2046-2054, 2006.
[24] Schibli, D. J., Epand, R. F., Vogel, H. J. et al., “Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions ” Biochemistry and Cell Biology, vol. 80, pp. 667-677, 2002.
[25] Zhao, H., Mattila, J.-P., Holopainen, J. M. et al., “Comparison of the Membrane Association of Two Antimicrobial Peptides, Magainin 2 and Indolicidin,” Biophysical Journal, vol. 81, no. 5, pp. 2979-2991, 2001.
[26] Chilukuri Subbalakshmi, N. S., “Mechanism of antimicrobial action of indolicidin,” FEMS Microbiology Letters, vol. 160, no. 1, pp. 91-96, 1998.
[27] Hsu, C.-H., Chen, C., Jou, M.-L. et al., “Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA,” Nucl. Acids Res., vol. 33, no. 13, pp. 4053-4064, 2005.
[28] Shaw, J. E., Alattia, J.-R., Verity, J. E. et al., “Mechanisms of antimicrobial peptide action: Studies of indolicidin assembly at model membrane interfaces by in situ atomic force microscopy,” Journal of Structural Biology, vol. 154, no. 1, pp. 42-58, 2006.
[29] Hsu, J. C. Y., and Yip, C. M., “Molecular Dynamics Simulations of Indolicidin Association with Model Lipid Bilayers,” Biophys. J., vol. 92, no. 12, pp. 100-102, 2007.
[30] Subbalakshmi, C., Krishnakumari, V., Nagaraj, R. et al., “Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide indolicidin,” FEBS Letters, vol. 395, no. 1, pp. 48-52, 1996.
[31] Subbalakshmi, C., Bikshapathy, E., Sitaram, N. et al., “Antibacterial and Hemolytic Activities of Single Tryptophan Analogs of Indolicidin,” Biochemical and Biophysical Research Communications, vol. 274, no. 3, pp. 714-716, 2000.
[32] Lakowicz, J. R., Principles of Fluorescence Spectroscopy 2nd ed.: Kluwer, 1999.
[33] Ladokhin, A. S., "Fluorescence Spectroscopy in Peptide and Protein Analysis," Encyclopedia of Analytical Chemistry, Meyers, R. A., ed., John Wiley & Sons Ltd, 2000, pp. 5762-5779.
[34] Andrushchenko, V. V., Aarabi, M. H., Nguyen, L. T. et al., “Thermodynamics of the interactions of tryptophan-rich cathelicidin antimicrobial peptides with model and natural membranes,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1778, no. 4, pp. 1004-1014, 2008.
[35] Papo, N., and Shai, Y., “Exploring Peptide Membrane Interaction Using Surface Plasmon Resonance: Differentiation between Pore Formation versus Membrane Disruption by Lytic Peptides,” Biochemistry, vol. 42, no. 2, pp. 458-466, 2003.
[36] Mechler, A., Praporski, S., Atmuri, K. et al., “Specific and Selective Peptide-Membrane Interactions Revealed Using Quartz Crystal Microbalance,” Biophysical Journal, vol. 93, no. 11, pp. 3907-3916, 2007.
[37] Ladokhin, A. S., Jayasinghe, S., and White, S. H., “How to Measure and Analyze Tryptophan Fluorescence in Membranes Properly, and Why Bother?,” Analytical Biochemistry, vol. 285, no. 2, pp. 235-245, 2000.
[38] Ana Lu´ cia C.F. Souto, E. F. P., Clo´ vis R. Nakaie, Shirley Schreier, “Fluorescence and circular dichroism study of the interaction between indolicidin, a tryptophan-rich antimicrobial peptide, and model membranes,” Progr Colloid Polym Sci, vol. 128, 2004.
[39] Zhao, H., and Kinnunen, P. K. J., “Binding of the Antimicrobial Peptide Temporin L to Liposomes Assessed by Trp Fluorescence,” J. Biol. Chem., vol. 277, no. 28, pp. 25170-25177, 2002.
[40] Kachel, K., Asuncion-Punzalan, E., and London, E., “Anchoring of Tryptophan and Tyrosine Analogs at the Hydrocarbon-Polar Boundary in Model Membrane Vesicles,” Biochemistry, vol. 34, no. 47, pp. 15475-15479, 1995.
[41] Caputo, G. A., and London, E., “Using a Novel Dual Fluorescence Quenching Assay for Measurement of Tryptophan Depth within Lipid Bilayers To Determine Hydrophobic a-Helix Locations within Membranes,” Biochemistry, vol. 42, no. 11, pp. 3265-3274, 2003.
[42] Kelkar, D. A., and Chattopadhyay, A., “Monitoring ion channel conformations in membranes utilizing a novel dual fluorescence quenching approach,” Biochemical and Biophysical Research Communications, vol. 343, no. 2, pp. 483-488, 2006.
[43] Royer, C. A., “Probing Protein Folding and Conformational Transitions with Fluorescence,” Chemical Reviews, vol. 106, no. 5, pp. 1769-1784, 2006.
[44] Ladokhin, A. S., Selsted, M. E., and White, S. H., “CD Spectra of Indolicidin Antimicrobial Peptides Suggest Turns, Not Polyproline Helix,” Biochemistry, vol. 38, no. 38, pp. 12313-12319, 1999.
|